Growth hormone therapy stories

Aug 7, 2026

Growth hormone therapy shows variable effectiveness in helping childhood stem cell transplant survivors achieve normal height

New research on hematopoietic stem cell transplantation (HCT) survivors reveals that while growth hormone therapy can help children who received transplants for life-threatening cancers and disorders grow taller, individual responses to treatment vary significantly.

Aug 7, 20261 source

Growth hormone therapy shows variable effectiveness in helping childhood stem cell transplant survivors achieve normal height

Aug 7, 20261 source

Top claims

▪Total body irradiation was identified as the strongest negative predictor of height in childhood hematopoietic stem cell transplantation survivors who underwent growth hormone therapy.
▪Growth outcomes after growth hormone therapy in childhood hematopoietic stem cell transplantation survivors are strongly influenced by transplant-related factors, including chronic graft-versus-host disease.
▪The pattern of growth improvement in childhood hematopoietic stem cell transplantation survivors receiving growth hormone therapy differs from the pattern typically observed in children with classical growth hormone deficiency.

Subtopics

Personalized medicine2

Related timelines